These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32410959)

  • 21. Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain.
    Yuill MB; Hale DE; Guindon J; Morgan DJ
    Mol Pain; 2017; 13():1744806917728227. PubMed ID: 28879802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OCP002, a Mixed Agonist of Opioid and Cannabinoid Receptors, Produces Potent Antinociception With Minimized Side Effects.
    Xu B; Zhang Q; Chen D; Zhang M; Zhang R; Zhao W; Qiu Y; Xu K; Xiao J; Niu J; Shi Y; Li N; Fang Q
    Anesth Analg; 2023 Feb; 136(2):373-386. PubMed ID: 36638515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models.
    Sala E; Ferrari F; Lanza M; Milia C; Sabatini C; Bonazzi A; Comi E; Borsi Franchini M; Caselli G; Rovati LC
    Br J Pharmacol; 2020 Jul; 177(14):3291-3308. PubMed ID: 32154915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice.
    Lee MT; Chen YH; Mackie K; Chiou LC
    J Pain; 2021 Mar; 22(3):300-312. PubMed ID: 33069869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine-induced antinociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism.
    Henderson-Redmond AN; Yuill MB; Lowe TE; Kline AM; Zee ML; Guindon J; Morgan DJ
    Brain Res Bull; 2016 May; 123():5-12. PubMed ID: 26521067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Slowly Signaling G Protein-Biased CB
    Lin X; Dhopeshwarkar AS; Huibregtse M; Mackie K; Hohmann AG
    Mol Pharmacol; 2018 Feb; 93(2):49-62. PubMed ID: 29192123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Cannabinoid Type 2 Receptor Agonist AM1241 on Morphine-Induced Antinociception, Acute and Chronic Tolerance, and Dependence in Mice.
    Zhang M; Dong L; Zou H; Li J; Li Q; Wang G; Li H
    J Pain; 2018 Oct; 19(10):1113-1129. PubMed ID: 29729431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
    Trang T; Sutak M; Jhamandas K
    Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine via Peripheral Opioid Receptors.
    Komla E; Stevens DL; Zheng Y; Zhang Y; Dewey WL; Akbarali HI
    J Pharmacol Exp Ther; 2019 Sep; 370(3):504-513. PubMed ID: 31248978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily intermittent fasting in mice enhances morphine-induced antinociception while mitigating reward, tolerance, and constipation.
    Duron DI; Hanak F; Streicher JM
    Pain; 2020 Oct; 161(10):2353-2363. PubMed ID: 32427747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid CB
    Guenther KG; Lin X; Xu Z; Makriyannis A; Romero J; Hillard CJ; Mackie K; Hohmann AG
    Biomed Pharmacother; 2024 Jul; 176():116879. PubMed ID: 38850666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain.
    Zhou Q; Wang J; Zhang X; Zeng L; Wang L; Jiang W
    Eur J Pharmacol; 2013 Oct; 718(1-3):17-23. PubMed ID: 24041921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid and cannabinoid synergy in a mouse neuropathic pain model.
    Kazantzis NP; Casey SL; Seow PW; Mitchell VA; Vaughan CW
    Br J Pharmacol; 2016 Aug; 173(16):2521-31. PubMed ID: 27278681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.